Literature DB >> 15285024

Impaired gallbladder motility and delayed orocecal transit contribute to pigment gallstone and biliary sludge formation in beta-thalassemia major adults.

Piero Portincasa1, Antonio Moschetta, Massimo Berardino, Agostino Di-Ciaula, Michele Vacca, Giuseppe Baldassarre, Anna Pietrapertosa, Rosario Cammarota, Nunzia Tannoia, Giuseppe Palasciano.   

Abstract

AIM: Gallbladder and gastrointestinal motility defects exist in gallstones patients and to a lesser extent in pigment gallstone patients. To investigated the role of gallbladder and gastrointestinal motility disorders in pigment gallstone formation in beta-thalassemia major.
METHODS: Twenty-three patients with beta-thalassemia major (16 females; age range 18-37 years) and 70 controls (47 females, age range 18-40 years) were studied for gallbladder and gastric emptying (functional ultrasonography), orocecal transit (OCTT, H(2)-breath test), autonomic dysfunction (sweat-spot, cardiorespiratory reflex tests), bowel habits, gastrointestinal symptoms and quality of life (all with questionnaires). Gallbladder content (ultrasonography) was examined before and during 8-12 mo follow-up.
RESULTS: Gallstones and/or biliary sludge were found in 13 (56%) patients. beta-thalassemia major patients had increased fasting (38.0+/-4.8 mL vs 20.3+/-0.7 mL, P = 0.0001) and residual (7.9+/-1.3 mL vs 5.1+/-0.3 mL, P = 0.002) volume and slightly slower emptying (24.9+/-1.7 min vs 20.1+/-0.7 min, P = 0.04) of the gallbladder, together with longer OCTT (132.2+/-7.8 min vs 99.7+/-2.3 min, P = 0.00003) than controls. No differences in gastric emptying and bowel habits were found. Also, patients had higher dyspepsia (score: 6.7+/-1.2 vs 4.9+/-0.2, P = 0.027), greater appetite (P = 0.000004) and lower health perception (P = 0.00002) than controls. Autonomic dysfunction was diagnosed in 52% of patients (positive tests: 76.2% and 66.7% for parasympathetic and sympathetic involvement, respectively). Patients developing sludge during follow-up (38%, 2 with prior stones) had increased fasting and residual gallbladder volume.
CONCLUSION: Adult beta-thalassemia major patients have gallbladder dysmotility associated with delayed small intestinal transit and autonomic dysfunction. These abnormalities apparently contribute together with haemolytic hyperbilirubinemia to the pathogenesis of pigment gallstones/sludge in beta-thalassemia major.

Entities:  

Mesh:

Year:  2004        PMID: 15285024      PMCID: PMC4576293          DOI: 10.3748/wjg.v10.i16.2383

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  64 in total

1.  Interdigestive gallbladder emptying, antroduodenal motility, and motilin release patterns are altered in cholesterol gallstone patients.

Authors:  M F Stolk; K J Van Erpecum; T L Peeters; M Samsom; A J Smout; L M Akkermans; G P Vanberge-Henegouwen
Journal:  Dig Dis Sci       Date:  2001-06       Impact factor: 3.199

2.  Standards for diagnosis of gastrointestinal motility disorders. Section: ultrasonography. A position statement from the Gruppo Italiano di Studio Motilità Apparato Digerente.

Authors:  P Portincasa; A Colecchia; A Di Ciaula; A Larocca; M Muraca; G Palasciano; E Roda; D Festi
Journal:  Dig Liver Dis       Date:  2000-03       Impact factor: 4.088

3.  Gallbladder motility and cholesterol crystallization in bile from patients with pigment and cholesterol gallstones.

Authors:  P Portincasa; A Di Ciaula; G Vendemiale; V Palmieri; A Moschetta; G P Vanberge-Henegouwen; G Palasciano
Journal:  Eur J Clin Invest       Date:  2000-04       Impact factor: 4.686

Review 4.  Pigment gallstone disease.

Authors:  B W Trotman
Journal:  Gastroenterol Clin North Am       Date:  1991-03       Impact factor: 3.806

5.  Measurement of gastric emptying time by real-time ultrasonography.

Authors:  L Bolondi; M Bortolotti; V Santi; T Calletti; S Gaiani; G Labò
Journal:  Gastroenterology       Date:  1985-10       Impact factor: 22.682

6.  Altered migrating myoelectrical complex in an animal model of cholesterol gallstone disease: the effect of erythromycin.

Authors:  Q W Xu; R B Scott; D T Tan; E A Shaffer
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

7.  Effect of mucous glycoprotein on nucleation time of human bile.

Authors:  S Gallinger; R D Taylor; P R Harvey; C N Petrunka; S M Strasberg
Journal:  Gastroenterology       Date:  1985-09       Impact factor: 22.682

8.  Diagnosis of diabetic autonomic neuropathy: a multivariate approach.

Authors:  P Diem; K Laederach-Hofmann; X Navarro; B Mueller; W R Kennedy; R P Robertson
Journal:  Eur J Clin Invest       Date:  2003-08       Impact factor: 4.686

9.  Correlation of cholecystokinin receptors with gallbladder contractility in patients with gallstones.

Authors:  J R Upp; W H Nealon; P Singh; C J Fagan; A S Jonas; G H Greeley; J C Thompson
Journal:  Ann Surg       Date:  1987-06       Impact factor: 12.969

10.  Sonographic evaluation of gallstone burden in humans.

Authors:  P Portincasa; A Di Ciaula; V Palmieri; G Vendemiale; E Altomare; G Palasciano
Journal:  Ital J Gastroenterol       Date:  1994-04
View more
  12 in total

1.  Subclinical autonomic dysfunction in patients with β-thalassemia.

Authors:  Elefterios Stamboulis; Nikoleta Vlachou; Konstantinos Voumvourakis; Athina Andrikopoulou; Chrisa Arvaniti; Athanasios Tsivgoulis; Dimitrios Athanasiadis; Sotirios Tsiodras; Nikolaos Tentolouris; Heleni Triantafyllidi; Marouso Drossou-Servou; Aphrodite Loutradi-Anagnostou; Georgios Tsivgoulis
Journal:  Clin Auton Res       Date:  2011-12-15       Impact factor: 4.435

Review 2.  Cholecystectomy and risk of metabolic syndrome.

Authors:  Agostino Di Ciaula; Gabriella Garruti; David Q-H Wang; Piero Portincasa
Journal:  Eur J Intern Med       Date:  2018-04-26       Impact factor: 4.487

3.  Impaired cholecystokinin-induced gallbladder emptying incriminated in spontaneous "black" pigment gallstone formation in germfree Swiss Webster mice.

Authors:  Stephanie E Woods; Monika R Leonard; Joshua A Hayden; Megan Brunjes Brophy; Kara R Bernert; Brigitte Lavoie; Sureshkumar Muthupalani; Mark T Whary; Gary M Mawe; Elizabeth M Nolan; Martin C Carey; James G Fox
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-12-04       Impact factor: 4.052

Review 4.  Mitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases.

Authors:  Carlotta Giorgi; Saverio Marchi; Ines C M Simoes; Ziyu Ren; Giampaolo Morciano; Mariasole Perrone; Paulina Patalas-Krawczyk; Sabine Borchard; Paulina Jędrak; Karolina Pierzynowska; Jędrzej Szymański; David Q Wang; Piero Portincasa; Grzegorz Węgrzyn; Hans Zischka; Pawel Dobrzyn; Massimo Bonora; Jerzy Duszynski; Alessandro Rimessi; Agnieszka Karkucinska-Wieckowska; Agnieszka Dobrzyn; Gyorgy Szabadkai; Barbara Zavan; Paulo J Oliveira; Vilma A Sardao; Paolo Pinton; Mariusz R Wieckowski
Journal:  Int Rev Cell Mol Biol       Date:  2018-06-22       Impact factor: 6.813

5.  Decreased postprandial gallbladder emptying in patients with black pigment stones.

Authors:  Takakazu Sugo; Kenichi Hakamada; Shunji Narumi; Mutsuo Sasaki
Journal:  World J Gastroenterol       Date:  2008-05-14       Impact factor: 5.742

6.  Gastrointestinal defects in gallstone and cholecystectomized patients.

Authors:  Agostino Di Ciaula; Emilio Molina-Molina; Leonilde Bonfrate; David Q-H Wang; Dan L Dumitrascu; Piero Portincasa
Journal:  Eur J Clin Invest       Date:  2019-01-29       Impact factor: 4.686

7.  Links between metabolic syndrome and cardiovascular autonomic dysfunction.

Authors:  G Garruti; F Giampetruzzi; M G Vita; F Pellegrini; P Lagioia; G Stefanelli; A Bellomo-Damato; F Giorgino
Journal:  Exp Diabetes Res       Date:  2012-03-15

8.  Cholelithiasis in Thalassemia Major Patients: A Report from the South-East of Iran.

Authors:  Iraj Shahramian; Razieh Behzadmehr; Mahdi Afshari; Atefeh Allahdadi; Mojtaba Delaramnasab; Ali Bazi
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2018-04-01

9.  The cerebral mechanism underlying the acupoints with specific effect for gallbladder stone disease: protocol for a randomized controlled task-fMRI trial.

Authors:  Ning Sun; Yuan-Fang Zhou; Jie Zhou; Wen-Wei Zuo; Xiang-Yin Ye; Xiao-Dong Deng; Zheng-Jie Li; Shi-Rui Cheng; Yu-Zhu Qu; Jun Zhou; Rui-Rui Sun; Fan-Rong Liang
Journal:  Trials       Date:  2021-06-14       Impact factor: 2.279

10.  Gastrointestinal symptoms and motility disorders in patients with systemic scleroderma.

Authors:  Agostino Di Ciaula; Michele Covelli; Massimo Berardino; David Q H Wang; Giovanni Lapadula; Giuseppe Palasciano; Piero Portincasa
Journal:  BMC Gastroenterol       Date:  2008-02-27       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.